Yakira Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.78M | Buy |
|
|||||
|
2023
Q4 | $726K | Hold |
|
|||||
|
2023
Q3 | $667K | Sell |
|
|||||
|
2023
Q2 | $789K | Sell |
|
|||||
|
2023
Q1 | $886K | Sell |
|
|||||
|
2022
Q4 | $982K | Sell |
|
|||||
|
2022
Q3 | $434K | Hold |
|
|||||
|
2022
Q2 | $689K | Buy |
|
|||||
|
2022
Q1 | $561K | Buy |
|
|||||
|
2021
Q4 | $287K | Buy |
|
|||||
|
2021
Q3 | $293K | Hold |
|
|||||
|
2021
Q2 | $387K | Hold |
|
|||||
|
2021
Q1 | $381K | Hold |
|
|||||
|
2020
Q4 | $418K | Sell |
|
|||||
|
2020
Q3 | $268K | Hold |
|
|||||
|
2020
Q2 | $223K | Hold |
|
|||||
|
2020
Q1 | $144K | Hold |
|
|||||
|
2019
Q4 | $211K | Hold |
|
|||||
|
2019
Q3 | $301K | Sell |
|
|||||
|
2019
Q2 | $405K | Hold |
|
|||||
|
2019
Q1 | $465K | Hold |
|
|||||
|
2018
Q4 | $258K | Hold |
|
|||||
|
2018
Q3 | $357K | Hold |
|
|||||
|
2018
Q2 | $329K | Sell |
|
|||||
|
2018
Q1 | $599K | Sell |
|
|||||
|
2017
Q4 | $861K | Buy |
|
|||||
|
2017
Q3 | $224K | Sell |
|
|||||
|
2017
Q2 | $311K | Buy |
|
|||||
|
2017
Q1 | $765K | Buy |
|